These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

359 related articles for article (PubMed ID: 21070867)

  • 21. PPARβ/δ Agonist Provides Neuroprotection by Suppression of IRE1α-Caspase-12-Mediated Endoplasmic Reticulum Stress Pathway in the Rotenone Rat Model of Parkinson's Disease.
    Tong Q; Wu L; Gao Q; Ou Z; Zhu D; Zhang Y
    Mol Neurobiol; 2016 Aug; 53(6):3822-3831. PubMed ID: 26160761
    [TBL] [Abstract][Full Text] [Related]  

  • 22. PPARβ/δ and lipid metabolism in the heart.
    Palomer X; Barroso E; Zarei M; Botteri G; Vázquez-Carrera M
    Biochim Biophys Acta; 2016 Oct; 1861(10):1569-78. PubMed ID: 26825692
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The PPARβ/δ agonist GW501516 attenuates peritonitis in peritoneal fibrosis via inhibition of TAK1-NFκB pathway in rats.
    Su X; Zhou G; Wang Y; Yang X; Li L; Yu R; Li D
    Inflammation; 2014 Jun; 37(3):729-37. PubMed ID: 24337677
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Induction of cardiac Angptl4 by dietary fatty acids is mediated by peroxisome proliferator-activated receptor beta/delta and protects against fatty acid-induced oxidative stress.
    Georgiadi A; Lichtenstein L; Degenhardt T; Boekschoten MV; van Bilsen M; Desvergne B; Müller M; Kersten S
    Circ Res; 2010 Jun; 106(11):1712-21. PubMed ID: 20378851
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Activated PPARβ/δ Protects Pancreatic β Cells in Type 2 Diabetic Goto-Kakizaki Rats from Lipoapoptosis via GPR40.
    Li J; Xu S; Liu Y; Yan Z; Zhang F; Lv Q; Tong N
    Lipids; 2019 Oct; 54(10):603-616. PubMed ID: 31364177
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Activation of peroxisome proliferator-activated receptor-{delta} by GW501516 prevents fatty acid-induced nuclear factor-{kappa}B activation and insulin resistance in skeletal muscle cells.
    Coll T; Alvarez-Guardia D; Barroso E; Gómez-Foix AM; Palomer X; Laguna JC; Vázquez-Carrera M
    Endocrinology; 2010 Apr; 151(4):1560-9. PubMed ID: 20185762
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Activation of PPARbeta/delta induces endothelial cell proliferation and angiogenesis.
    Piqueras L; Reynolds AR; Hodivala-Dilke KM; Alfranca A; Redondo JM; Hatae T; Tanabe T; Warner TD; Bishop-Bailey D
    Arterioscler Thromb Vasc Biol; 2007 Jan; 27(1):63-9. PubMed ID: 17068288
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The transcriptional PPARβ/δ network in human macrophages defines a unique agonist-induced activation state.
    Adhikary T; Wortmann A; Schumann T; Finkernagel F; Lieber S; Roth K; Toth PM; Diederich WE; Nist A; Stiewe T; Kleinesudeik L; Reinartz S; Müller-Brüsselbach S; Müller R
    Nucleic Acids Res; 2015 May; 43(10):5033-51. PubMed ID: 25934804
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Synthesis of isosteric selenium analog of the PPARbeta/delta agonist GW501516 and comparison of biological activity.
    Sharma AK; Sk UH; He P; Peters JM; Amin S
    Bioorg Med Chem Lett; 2010 Jul; 20(14):4050-2. PubMed ID: 20542425
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Carnitine palmitoyltransferase-1 up-regulation by PPAR-β/δ prevents lipid-induced endothelial dysfunction.
    Toral M; Romero M; Jiménez R; Mahmoud AM; Barroso E; Gómez-Guzmán M; Sánchez M; Cogolludo Á; García-Redondo AB; Briones AM; Vázquez-Carrera M; Pérez-Vizcaíno F; Duarte J
    Clin Sci (Lond); 2015 Nov; 129(9):823-37. PubMed ID: 26253087
    [TBL] [Abstract][Full Text] [Related]  

  • 31. PPARbeta/delta agonist increases the expression of PGE2 receptor subtype EP4 in human lung carcinoma cells.
    Ritzenthaler JD; Roman J; Han S
    Methods Mol Biol; 2009; 512():309-23. PubMed ID: 19347285
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Ligand activation of peroxisome proliferator-activated receptor beta/delta (PPARbeta/delta) attenuates carbon tetrachloride hepatotoxicity by downregulating proinflammatory gene expression.
    Shan W; Palkar PS; Murray IA; McDevitt EI; Kennett MJ; Kang BH; Isom HC; Perdew GH; Gonzalez FJ; Peters JM
    Toxicol Sci; 2008 Oct; 105(2):418-28. PubMed ID: 18622026
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Complementary Immunometabolic Effects of Exercise and PPARβ/δ Agonist in the Context of Diet-Induced Weight Loss in Obese Female Mice.
    Le Garf S; Murdaca J; Mothe-Satney I; Sibille B; Le Menn G; Chinetti G; Neels JG; Rousseau AS
    Int J Mol Sci; 2019 Oct; 20(20):. PubMed ID: 31635041
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Peroxisome proliferator-activated receptor (PPAR)-gamma positively controls and PPARalpha negatively controls cyclooxygenase-2 expression in rat brain astrocytes through a convergence on PPARbeta/delta via mutual control of PPAR expression levels.
    Aleshin S; Grabeklis S; Hanck T; Sergeeva M; Reiser G
    Mol Pharmacol; 2009 Aug; 76(2):414-24. PubMed ID: 19483106
    [TBL] [Abstract][Full Text] [Related]  

  • 35. PPARβ/δ prevents endoplasmic reticulum stress-associated inflammation and insulin resistance in skeletal muscle cells through an AMPK-dependent mechanism.
    Salvadó L; Barroso E; Gómez-Foix AM; Palomer X; Michalik L; Wahli W; Vázquez-Carrera M
    Diabetologia; 2014 Oct; 57(10):2126-35. PubMed ID: 25063273
    [TBL] [Abstract][Full Text] [Related]  

  • 36. PPARβ/δ Agonism Upregulates Forkhead Box A2 to Reduce Inflammation in C2C12 Myoblasts and in Skeletal Muscle.
    Phua WWT; Tan WR; Yip YS; Hew ID; Wee JWK; Cheng HS; Leow MKS; Wahli W; Tan NS
    Int J Mol Sci; 2020 Mar; 21(5):. PubMed ID: 32143325
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Apoptotic effect of the selective PPARβ/δ agonist GW501516 in invasive bladder cancer cells.
    Péchery A; Fauconnet S; Bittard H; Lascombe I
    Tumour Biol; 2016 Nov; 37(11):14789-14802. PubMed ID: 27638828
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Rosiglitazone induces interleukin-1 receptor antagonist in interleukin-1beta-stimulated rat synovial fibroblasts via a peroxisome proliferator-activated receptor beta/delta-dependent mechanism.
    Moulin D; Bianchi A; Boyault S; Sebillaud S; Koufany M; Francois M; Netter P; Jouzeau JY; Terlain B
    Arthritis Rheum; 2005 Mar; 52(3):759-69. PubMed ID: 15751073
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Harnessing the benefits of PPARβ/δ agonists.
    Mackenzie LS; Lione L
    Life Sci; 2013 Dec; 93(25-26):963-7. PubMed ID: 24184294
    [TBL] [Abstract][Full Text] [Related]  

  • 40. TNF-alpha reduces PGC-1alpha expression through NF-kappaB and p38 MAPK leading to increased glucose oxidation in a human cardiac cell model.
    Palomer X; Alvarez-Guardia D; Rodríguez-Calvo R; Coll T; Laguna JC; Davidson MM; Chan TO; Feldman AM; Vázquez-Carrera M
    Cardiovasc Res; 2009 Mar; 81(4):703-12. PubMed ID: 19038972
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 18.